Funding Resources
Funding Overview
Funding Strategy

Funding Opportunities

Grant Mechanisms
Training & Career
   Development
Contracts Management
Review Committees
Funding News
Program Areas

Research
Anticonvulsant Screening
   Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research
Parkinson's Web
Resources for Scientists
Stem Cell Research
Translational Research
Traumatic Brain Injury
   (TBI) Research
Technology Transfer
   Office

Contact Us
My Privacy

NINDS is part of the
National Institutes of
Health

Download Adobe Reader

  Print-friendly version

   Email this page

Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transition by registering with Grants.gov and NIH eRA Commons now.

---

RFI: Preclinical Development Facility for Medical Countermeasures Against Chemical Threats
Release Date: September 2, 2005
Announcement Number: NOT-NS-05-012

Funding Contact: Helene Braun
Program Area: Technology Development, Contracts Management Branch

Brief Description:
The National Institute of Neurological Disorders and Stroke (NINDS) is considering issuing a contract for preclinical studies of new or improved pharmaceutical preparations to be used as medical countermeasures against chemical agents that could be used in a terrorist attack. As a first step, the Institute is attempting to identify expert sources to conduct safety, pharmacokinetic/biodistribution, and developmental chemistry studies with candidate drugs.

Choose an option to view additional funding announcements

New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives